| 2/22/23 |
Vir Biotechnology Announces Positive Final Draft Guidance on Sotrovimab from the UK’s National Institute for Health and Care Excellence (NICE) |
| 2/16/23 |
Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 |
| 2/16/23 |
Vir Biotechnology Appoints Sung Lee as Chief Financial Officer |
| 2/13/23 |
Vir Biotechnology Announces Amended Collaboration Agreement with GSK |
| 1/25/23 |
Vir Biotechnology Announces Retirement of CEO George Scangos, Ph.D.; Appoints Marianne De Backer, MSc, Ph.D., MBA, as Successor |
| 1/3/23 |
Vir Biotechnology to Highlight Anticipated 2023 Catalysts and Long-Term Growth Strategy at 41st Annual J.P. Morgan Healthcare Conference |
